Dale Broadrick - 17 Jun 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Issuer symbol
BRTX
Transactions as of
17 Jun 2022
Net transactions value
+$2,650
Form type
4
Filing time
23 Jun 2022, 15:42:17 UTC
Previous filing
17 Jun 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $2,282 +600 +0.2% $3.80 295,373 17 Jun 2022 Direct F1
transaction BRTX Common Stock Purchase $368 +100 +0.03% $3.68 295,473 21 Jun 2022 Direct
holding BRTX Common Stock 316,972 17 Jun 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 125 17 Jun 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 125 17 Jun 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 17 Jun 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 17 Jun 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 17 Jun 2022 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $3.69 to $3.9375 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F2 Owned by Fleetco, Inc. of which reporting person is a 93% shareholder.